Brunel was established in 1974 by Mr Dawie de Bruin and Mr Louis Nel. The company was based in Centurion, South Africa and was originally launched doing third party sales predominantly for Beige Pharmaceuticals and the sale of its first product, a specialised hand and body lotion called Lotio Brunel, which is still on the market today.
In 1978 Brunel acquired the Famucaps Brand. In 1979 Brunel acquired a further range of pharmaceutical products. In 1986 Brunel moved into the building at 1 Van Tonder Street, Sunderland Ridge, Pretoria and obtained all necessary regulatory licenses.
In 2010 Calibre Capital acquired Brunel. Following the acquisition of Brunel many changes were made which included management, the launch of new products, key acquisitions and solid organic growth.
In 2022, a private equity consortium comprising RMB Corvest and Umoya Capital Partners have, alongside management and Calibre Capital, invested in Brunel Laboratoria (Pty) Ltd. The official RMB press release can be viewed here.